about
Effects of d-chiro-inositol in lean women with the polycystic ovary syndromeAltered D-chiro-inositol urinary clearance in women with polycystic ovary syndromeIntegrated obesity care management system -implementation and research protocol.Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.Basic infertility including polycystic ovary syndrome.Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome.Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study.Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis.Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity.Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndromeA modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills.Insulin sensitizers for polycystic ovary syndrome.Intergenerational cycle of obesity and diabetes: how can we reduce the burdens of these conditions on the health of future generations?Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome.Impact of an integrated obesity management system on patient's care - research protocolThe Obesity-Fertility Protocol: a randomized controlled trial assessing clinical outcomes and costs of a transferable interdisciplinary lifestyle intervention, before and during pregnancy, in obese infertile women.Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance.Use of insulin sensitizers in polycystic ovarian syndrome.Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndromePilot study: can older inactive adults learn how to reach the required intensity of physical activity guideline?Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study.Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome.Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns.Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity.Insulin and hyperandrogenism in women with polycystic ovary syndrome.Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells.Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases.Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome.Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic statusOral hypoglycemic agents for gestational diabetes mellitus?PCOS in adolescence and type 2 diabetes.Alanine Aminotransferase Is a Marker of Lipotoxicity Consequences and Hyperandrogenemia in Women with Polycystic Ovary Syndrome.Age differences in expectations and readiness regarding lifestyle modifications in individuals at high risk of diabetes.Metabolically healthy obese women and functional capacity.Effectiveness of a multidisciplinary program for management of obesity: the Unité d'Enseignement, de Traitement et de Recherche sur l'Obésité (UETRO) database study.The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and β-cell function.
P50
Q28271889-F1DDF632-BE61-4E23-9D29-2059E1254FF7Q28294415-4CF2EA39-1CF1-4598-8598-8F81B1ED5CAAQ33302215-A0506AFF-75E0-4513-9845-59A00B01A0DFQ34011558-30878358-1114-4BC8-BE27-CFCE8B622A1FQ34013489-50A8F635-E630-450E-8FBF-79AA930EC3E8Q34161009-0DE0735A-172F-43ED-88F5-DA669941DCE0Q34229170-569F90FA-D714-4A57-B240-64B74D0FB904Q34351640-5A11FF4E-B4A5-40C8-BED9-E212D6B3227AQ34409440-457277F6-601E-4D62-9966-8618F1D6B379Q34896686-D857AD3A-F8CD-4BA1-B0C2-8936EC367504Q35117211-661F4B4B-9420-4EB4-8B62-9B77EBA1CE7EQ35120058-F9EEAF6B-77E8-4859-8E40-AA0A5014E003Q35155109-9747A651-6C82-4643-8706-7B5D97D1A5D2Q35496158-744B2FAD-E6ED-4B3B-A46C-BA50E9261408Q35688517-6015AFEE-2666-42A5-A6B2-B292DD4FF01AQ35718394-EAB55035-FD93-4F7F-B603-15888D59F558Q35860762-A5EB4F3B-09BF-4311-A8B6-63882C67D557Q35864473-A7FA1EFF-A11A-49D5-99AE-E39720160FAAQ36301404-0276E059-1A9C-4F66-BAC0-A334EA0580D9Q36303511-136E4E1A-5B22-4838-B1A1-9A669CAAE54AQ36334951-D9510D6B-8279-4DCA-BFCA-4545EE1BF757Q36822655-B6B9FC49-0A10-4C95-8591-067CE5EC1BA8Q36897081-9C13EDBA-E29A-4708-B28A-4B6A80D9DD8EQ36951616-9AF22D75-725C-4AB6-AA5D-A68B7851C6ECQ36958256-2218F42F-26BB-4839-9AB7-B53711D27B3FQ37031287-162038C3-798A-4485-B189-E312B6376BB0Q37310914-07682F1C-629A-4953-8E09-25DA32596B1EQ37355743-2D442E08-2A61-47D6-872F-2E6A6BF45F7FQ37355746-8CD08680-C398-451A-A693-49008860CB02Q37360333-A1CA0F71-1765-43A4-ABC2-A50E34346178Q37445227-346DCCA3-241D-429B-839E-CCC0FCA41376Q37515575-B9AC7AD3-F51B-475A-9DF6-AEAE6628AD2EQ37600914-3F7C7550-C1F7-493E-85E1-4668DE99309FQ37826425-5F3D11BA-C66C-4553-8243-1B46F526DD1DQ38268267-62553A82-22BD-4678-9606-782C7AEC0911Q39198717-959D3AA2-7308-4219-B6BC-54A3B5D9A244Q39632808-CEF7054E-DFD3-4119-A588-52252BE859ECQ39777252-11572760-C24A-48F2-9686-984F871FD56FQ39967734-A58879DD-2F6D-4299-A956-B7B47D9C8190Q40778501-F92CE0AA-7D25-4A41-B2CA-742045C44A0A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jean-Patrice Baillargeon
@ast
Jean-Patrice Baillargeon
@en
Jean-Patrice Baillargeon
@es
Jean-Patrice Baillargeon
@nl
Jean-Patrice Baillargeon
@sl
type
label
Jean-Patrice Baillargeon
@ast
Jean-Patrice Baillargeon
@en
Jean-Patrice Baillargeon
@es
Jean-Patrice Baillargeon
@nl
Jean-Patrice Baillargeon
@sl
prefLabel
Jean-Patrice Baillargeon
@ast
Jean-Patrice Baillargeon
@en
Jean-Patrice Baillargeon
@es
Jean-Patrice Baillargeon
@nl
Jean-Patrice Baillargeon
@sl
P106
P21
P31
P496
0000-0002-1336-081X